MedTrace Logo

TR(ACE) Assay Clinical Specimen Study

NCT02934360 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 450

Last updated 2018-01-18

No results posted yet for this study

Summary

The TR(ACE) Assay is a quantitative in vitro diagnostic test run on the TR(ACE) Instrument intended for the measurement of high molecular weight human DNA from plasma as an aid to monitoring disease progression or response to therapy or recurrent or residual disease.

Conditions

  • Carcinoma, Non-Small-Cell Lung
  • Breast Neoplasms

Interventions

DEVICE

TR(ACE) Assay Testing

Serial plasma testing with TR(ACE) Assay

Sponsors & Collaborators

  • Biological Dynamics

    lead INDUSTRY

Principal Investigators

  • Robert Kovelman · Biological Dynamics

Eligibility

Min Age
21 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-09-30
Primary Completion
2018-01-31
Completion
2018-04-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02934360 on ClinicalTrials.gov